Helius Medical Technologies is trading at $3.27 (+5.14%) amid continued momentum following gains on September 18 and September 21.
- No clear company-specific announcement dated September 22, 2026 was identified; available evidence does not establish a definitive catalyst.
- The move also comes alongside broader risk appetite and interest in the company’s Solana-treasury strategy.
- Recent analyst commentary raised fair value to $3.25 from $2.75, but predates today’s move; latest coverage centers on earlier financial results and strategy developments.